Related by context. Frequent words. (Click for all words.) 69 median PFS 64 plus prednisone 64 FOLFIRI 64 free survival PFS 61 P = .# 60 neoadjuvant 59 chemoradiation 59 LVEF 59 Secondary endpoints 59 azathioprine 59 thromboembolic events 59 mitoxantrone 59 vinorelbine 58 metastatic renal cell carcinoma 58 evaluable 58 Secondary endpoints included 58 FOLFOX 58 evaluable patients 57 Secondary endpoints include 57 febrile neutropenia 57 plus methotrexate 57 RECIST criteria 57 confidence interval #.#-#.# 57 annualized relapse 57 azacitidine 57 virologic failure 57 cytogenetic response 57 adjuvant chemotherapy 57 neoadjuvant chemotherapy 56 tumor recurrence 56 fluorouracil 56 Median survival 56 placebo p = 56 unfractionated heparin 56 sustained virologic response 55 nonresponders 55 dacarbazine 55 abciximab 55 nab paclitaxel 55 diagnosed multiple myeloma 55 gemcitabine 55 interferon alfa 55 tiotropium 55 bosentan 55 distant metastases 55 tumor shrinkage 54 composite endpoint 54 reoperation 54 secondary efficacy endpoints 54 Postoperative 54 thromboembolism 54 etanercept 54 sinus rhythm 54 pemetrexed 54 statistically significant improvement 54 mcg kg 54 discontinuations due 54 leukopenia 54 decitabine 54 % CI #.#-#.# [006] 54 mg BID 54 nilotinib 54 noninferiority 54 laboratory abnormalities 53 colectomy 53 peginterferon alfa 2b 53 nephrectomy 53 HbA1c levels 53 erlotinib 53 peginterferon 53 tumor regression 53 postoperatively 53 p = #.# [004] 53 Torisel 53 stent implantation 53 confidence interval CI 53 subgroup analyzes 53 Cmax 53 adalimumab 53 dasatinib 53 serum phosphorus 53 Pharmacokinetic 53 sunitinib 53 trastuzumab 53 anastrozole 53 epirubicin 53 target lesion revascularization 53 imetelstat 53 thrombotic events 53 D dimer 53 plus ribavirin 53 p = #.# [002] 53 relapsed refractory 53 docetaxel 53 events SAEs 53 temsirolimus 53 cetuximab 53 peginterferon alfa 2a 53 DMARD 53 #mg dose [003] 52 degarelix